Evidence map›Paper›PMID 32089143›Full record

ArticleEpidemiology and infection2020

Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016.

A von Laer, M Diercke, M An der Heiden, D Altmann, R Zimmermann, S Dudareva

Abstract read
In one paragraph

Article in Epidemiology and infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A von LaerPostgraduate Training for Applied Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-4010-1714
M DierckeDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
M An der HeidenDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
D AltmannDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
R ZimmermannDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
S DudarevaDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-1803-704X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2015, the number of hepatitis B virus (HBV) cases increased substantially in Germany. In 2015, a more sensitive HBV case definition was introduced. This coincided with an asylum seeker influx with differing screening strategies. Information on the asylum seeker status has been collected since 09/2015. We investigated this increase to interpret HBV notification data in Germany. We compared HBV surveillance data from 2010-2013 (baseline) with 2015-2016, excluding 2014 due to beginning of asylum seeker influx. We estimated the excess above the mean case number (baseline) using Poisson regression and compared asylum seeker cases and the excess of cases with the unknown asylum seeker status. HBV cases increased from 1855 (mean baseline) to 3873 (2015) and 3466 (2016) with 1903 asylum seeker cases and 1099 excess-cases with the unknown asylum seeker status in 2015-2016. Cases only fulfilling the changed case definition increased from 60% (1119) in baseline to 81% (P < 0.01) in 2015-2016; 69% of asylum seeker cases and 61% of excess-cases were males <40 years compared to 27% (baseline) (P < 0.01). Changed case definition increased the number of cases in official statistics substantially. Demographic and geographical distributions suggest that screening of asylum seekers increased the case numbers even to a higher extent than surveillance data indicates.

Indexed as

Epidemiological MonitoringRefugeesAdultFemaleGermanyHepatitis BHumansMaleMass ScreeningMiddle AgedEpidemiological surveillanceGermanyhepatitis Brefugees

Identifiers

PMID32089143
PMCPMC7058648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.